Evidence map›Paper›PMID 41469398›Full record

ArticleNature communications2025

Modular assembly of chiral amino acid derivatives and peptides from commonly available feedstocks.

Wei-Wei Ding, Zhi-Yuan He, Wan-Yu Wang, Zhi-Yong Han, Liu-Zhu Gong

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Wei-Wei DingHefei National Laboratory for Physical Sciences at the Microscale and Department of Chemistry, University of Science and Technology of China, Hefei, China.
Zhi-Yuan HeHefei National Laboratory for Physical Sciences at the Microscale and Department of Chemistry, University of Science and Technology of China, Hefei, China.
Wan-Yu WangHefei National Laboratory for Physical Sciences at the Microscale and Department of Chemistry, University of Science and Technology of China, Hefei, China.
Zhi-Yong HanHefei National Laboratory for Physical Sciences at the Microscale and Department of Chemistry, University of Science and Technology of China, Hefei, China. hanzy2014@ustc.edu.cn.ORCID http://orcid.org/0000-0002-9225-5064
Liu-Zhu GongHefei National Laboratory for Physical Sciences at the Microscale and Department of Chemistry, University of Science and Technology of China, Hefei, China. gonglz@ustc.edu.cn.ORCID http://orcid.org/0000-0001-6099-827X

Funding

National Natural Science Foundation of China (National Science Foundation of China) 22471255
6 · The paper itself

Abstract

α-Amino acids are fundamental components of proteins and natural molecules, with non-natural variants highly valued in both academia and industry for their ability to tune chemical, physical, and pharmaceutical properties. Herein, we report a photoredox-catalyzed protocol for the synthesis of optically active α-amino amides from readily available aldehydes, amines, and formamides. A dual catalytic system combining a chiral sodium phosphate with tetrabutylammonium decatungstate (TBADT) under visible light enables this transformation. The process achieves high enantioselectivity and allows two-step conversion to free amino acids without significant racemization. Consequently, diverse, synthetically useful structures-including β-branched and α,β-diamino acid derivatives, glycosylated amino acids, isotopically labeled compounds (deuterium and

Indexed as

Amino AcidsPeptidesAldehydesAmidesAminesCatalysisOxidation-ReductionQuaternary Ammonium CompoundsStereoisomerismAldehydesAmidesAminesAmino AcidsPeptidesQuaternary Ammonium Compoundstetrabutylammonium

Identifiers

PMID41469398
PMCPMC12868840

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.